Irish drug trial technology firm Teckro wins $25 million injection

Barclays’ British online banking channels go down in latest outage
February 14, 2019
EU agrees to curb unfair practices by tech giants, booking sites
February 14, 2019
This post was originally published on this site

Ireland’s Teckro, which makes software that allows physicians to take part in drug development trials from mobile devices, has won $25 million in financial backing from investors, as it hatches longer-term plans for a stock market listing.